AU2001252917A1 - 7 human ovarian and ovarian cancer associated proteins - Google Patents
7 human ovarian and ovarian cancer associated proteinsInfo
- Publication number
- AU2001252917A1 AU2001252917A1 AU2001252917A AU5291701A AU2001252917A1 AU 2001252917 A1 AU2001252917 A1 AU 2001252917A1 AU 2001252917 A AU2001252917 A AU 2001252917A AU 5291701 A AU5291701 A AU 5291701A AU 2001252917 A1 AU2001252917 A1 AU 2001252917A1
- Authority
- AU
- Australia
- Prior art keywords
- ovarian
- associated proteins
- cancer associated
- human
- ovarian cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010033128 Ovarian cancer Diseases 0.000 title 1
- 206010061535 Ovarian neoplasm Diseases 0.000 title 1
- 230000002611 ovarian Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19007600P | 2000-03-17 | 2000-03-17 | |
US60190076 | 2000-03-17 | ||
US22700900P | 2000-08-23 | 2000-08-23 | |
US60227009 | 2000-08-23 | ||
PCT/US2001/008585 WO2001070804A1 (en) | 2000-03-17 | 2001-03-16 | 7 human ovarian and ovarian cancer associated proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001252917A1 true AU2001252917A1 (en) | 2001-10-03 |
Family
ID=26885755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001252917A Abandoned AU2001252917A1 (en) | 2000-03-17 | 2001-03-16 | 7 human ovarian and ovarian cancer associated proteins |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1268541A1 (en) |
JP (1) | JP2003527851A (en) |
AU (1) | AU2001252917A1 (en) |
CA (1) | CA2400638A1 (en) |
WO (1) | WO2001070804A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030044813A1 (en) * | 2001-03-30 | 2003-03-06 | Old Lloyd J. | Cancer-testis antigens |
AU2002254615A1 (en) * | 2001-04-17 | 2002-10-28 | The Board Of Trustees Of The University Of Arkansas | Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
US7309760B2 (en) | 2001-04-17 | 2007-12-18 | The Board Of Trustees Of The University Of Arkansas | Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
RS20050300A (en) | 2002-10-16 | 2007-08-03 | Euro-Celtique S.A., | Antibodies that bind cell-associated ca 125/0772p and methods of use thereof |
NZ570201A (en) * | 2003-02-11 | 2011-03-31 | Shire Human Genetic Therapies | Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (fge) |
EP2056110A1 (en) * | 2007-10-31 | 2009-05-06 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment |
US20160145589A1 (en) | 2011-06-24 | 2016-05-26 | Green Cross Corporation | Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof |
KR101380740B1 (en) | 2012-06-29 | 2014-04-11 | 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 | Purification of iduronate-2-sulfatase |
US9150841B2 (en) | 2012-06-29 | 2015-10-06 | Shire Human Genetic Therapies, Inc. | Cells for producing recombinant iduronate-2-sulfatase |
BR112017002888A2 (en) | 2014-08-12 | 2017-12-05 | Nextgen Jane Inc | system and method for health monitoring in body fluid collected |
EP3442706A4 (en) | 2016-04-13 | 2020-02-19 | NextGen Jane, Inc. | Sample collection and preservation devices, systems and methods |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5457038A (en) * | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
-
2001
- 2001-03-16 AU AU2001252917A patent/AU2001252917A1/en not_active Abandoned
- 2001-03-16 WO PCT/US2001/008585 patent/WO2001070804A1/en not_active Application Discontinuation
- 2001-03-16 CA CA002400638A patent/CA2400638A1/en not_active Abandoned
- 2001-03-16 EP EP01926376A patent/EP1268541A1/en not_active Withdrawn
- 2001-03-16 JP JP2001569004A patent/JP2003527851A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2003527851A (en) | 2003-09-24 |
WO2001070804A1 (en) | 2001-09-27 |
EP1268541A1 (en) | 2003-01-02 |
CA2400638A1 (en) | 2001-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AUPR814401A0 (en) | Human 3 relaxin | |
AU7058000A (en) | 13 human colon and colon cancer associated proteins | |
AU1608201A (en) | Human zven proteins | |
AU2001252917A1 (en) | 7 human ovarian and ovarian cancer associated proteins | |
AU2001286721A1 (en) | Human interleukin-four induced protein | |
AU2002243314A1 (en) | Immunogenic cancer peptides and uses thereof | |
AU7089800A (en) | 29 human cancer associated proteins | |
GB0200204D0 (en) | Cosmetic and related preparations | |
AU2002312373A1 (en) | Structural and cytoskeleton-associated proteins | |
AU6111800A (en) | 26 human prostate and prostate cancer associated proteins | |
AU2002341828A1 (en) | Enhanced proteins and methods for their use | |
AU2001241875A1 (en) | Human dynamin 40322 | |
AU2136401A (en) | P450rai-2 and related proteins | |
AU2001263287A1 (en) | Human protein kinase "13305" and uses therefor | |
AU3411999A (en) | Novel rnase-like protein and its use | |
AU4992099A (en) | Human presenilin-associated protein | |
AU2593199A (en) | Human smn-like protein | |
AU4438599A (en) | Human arf-related proteins | |
AU2001231141A1 (en) | Novel human septin and uses thereof | |
AU2002360333A1 (en) | Human angiomotin-like protein 1 | |
AU2001250047A1 (en) | Effector-specific protein assembly and uses thereof | |
AU2002343516A1 (en) | Structural and cytoskeleton-associated proteins | |
AU2002320621A1 (en) | Structural and cytoskeleton-associated proteins | |
AU2001255763A1 (en) | 13295 novel protein kinase molecules and uses therefor | |
AU2001279046A1 (en) | 18431 and 32374, human protein kinase family members and uses therefor |